Skip to main content

Table 6 Drug recovery (%) in ASAQ bilayer tablets after 6 months in various aging conditions.

From: The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

  

25°C/60%RH

30°C/65%RH

40°C/75%RH

High dosage tablets

AS (%)

100.2

100.7

96.1

 

AQ (%)

100.3

102.0

99.6

Low dosage tablets

AS (%)

102.0

102.0

99.2

 

AQ (%)

101.7

102.7

101.8

  1. Batches 30154C03 and 30154C04 for high and low dosage respectively, DHA < 0,5%
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us